Periprocedural management of the anticoagulated patient can be as easy as continuing warfarin for a low bleeding risk procedure, holding a direct oral anticoagulant for 1 day prior and resuming 1 day later or as complex as emergent reversal with prothrombin complex concentrate, idarucizumab, or andexanet alfa. Patient-specific factors for thromboembolic risk and procedural bleeding risk determine timing of anticoagulation hold prior to and resumption after invasive procedures. Clinical trials and management studies in recent years have helped inform our approach to these patients, but much of the guidance is still based on expert consensus
If patients being treated with anticoagulants need to undergo an operation then physicians need to c...
Perioperative management of antithrombotic therapy in patients treated with coronary stents undergoi...
More than 2 million people are currently treated withoral anticoagulation in North America alone.1 I...
Periprocedural management of the anticoagulated patient can be as easy as continuing warfarin for a ...
About 10% of patients taking a chronic, oral anticoagulant therapy require an invasive procedure tha...
Perioperative management of antithrombotic therapy is a situation that occurs frequently and require...
AbstractMany patients on chronic warfarin therapy are undergoing surgery for permanent pacemakers an...
If patients being treated with anticoagulants need to undergo an operation then physicians need to c...
The periprocedural management of anticoagulation in patients who require non-cardiac surgery is a co...
Anticoagulants are prescribed for diseases carrying a thromboembolic risk. In clinical practice it i...
Perioperative thrombosis and hemostasis management has changed dramatically over the past 50 years. ...
Anticoagulants are effective agents in reducing the risk of thromboembolism but the most important a...
Direct oral anticoagulants (DOACs) have been licensed worldwide for several years for various indica...
The management of antithrombotic therapy in the perioperative setting is a common problem, balancing...
International audienceSince 2011, data on patients exposed to direct oral anticoagulants (DOAs) whil...
If patients being treated with anticoagulants need to undergo an operation then physicians need to c...
Perioperative management of antithrombotic therapy in patients treated with coronary stents undergoi...
More than 2 million people are currently treated withoral anticoagulation in North America alone.1 I...
Periprocedural management of the anticoagulated patient can be as easy as continuing warfarin for a ...
About 10% of patients taking a chronic, oral anticoagulant therapy require an invasive procedure tha...
Perioperative management of antithrombotic therapy is a situation that occurs frequently and require...
AbstractMany patients on chronic warfarin therapy are undergoing surgery for permanent pacemakers an...
If patients being treated with anticoagulants need to undergo an operation then physicians need to c...
The periprocedural management of anticoagulation in patients who require non-cardiac surgery is a co...
Anticoagulants are prescribed for diseases carrying a thromboembolic risk. In clinical practice it i...
Perioperative thrombosis and hemostasis management has changed dramatically over the past 50 years. ...
Anticoagulants are effective agents in reducing the risk of thromboembolism but the most important a...
Direct oral anticoagulants (DOACs) have been licensed worldwide for several years for various indica...
The management of antithrombotic therapy in the perioperative setting is a common problem, balancing...
International audienceSince 2011, data on patients exposed to direct oral anticoagulants (DOAs) whil...
If patients being treated with anticoagulants need to undergo an operation then physicians need to c...
Perioperative management of antithrombotic therapy in patients treated with coronary stents undergoi...
More than 2 million people are currently treated withoral anticoagulation in North America alone.1 I...